Literature DB >> 2882804

Effects of 5-hydroxy-propafenone in guinea-pig atrial fibres.

C Delgado, J Tamargo, T Tejerina, C Valenzuela.   

Abstract

The effects of 5-hydroxy-propafenone (5-OH-P), an active metabolite of propafenone, were studied on isolated atrial muscle fibres obtained from non-treated guinea-pigs and from animals pretreated with 5-OH-P, 3 mg kg-1, for 28 days. In untreated atria 5-OH-P, 10(-8) M-10(-4) M, produced a dose-dependent decrease in amplitude and df/dtmax and reduced the amplitude of the slow contractions induced by isoprenaline and histamine in high K+ media. 5-OH-P also produced a dose-dependent decrease in atrial rate, prolonged the sinus node recovery time and reduced the maximum chronotropic responses to isoprenaline. In untreated atrial muscle fibres 5-OH-P depressed action potential amplitude and Vmax, reduced the resting membrane potential and prolonged the action potential duration (ADP) and the effective refractory period, lengthening the effective refractory period relative to APD. Pretreatment with 5-OH-P reduced atrial rate and increased contractile force, but did not modify the action potential characteristics from the values obtained in untreated atria. Further addition of 5-OH-P produced similar but more marked changes than in untreated atria. It is concluded that in guinea-pig isolated atrial muscle fibres 5-OH-P, like propafenone, exhibits class I (membrane stabilizing), class II (antisympathetic) and class IV (Ca antagonistic) antiarrhythmic actions. Therefore, this metabolite could be responsible, at least in part, for some of the antiarrhythmic effects previously attributed to propafenone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882804      PMCID: PMC1917170          DOI: 10.1111/j.1476-5381.1987.tb11208.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  The multiple modes of action of propafenone.

Authors:  I D Dukes; E M Vaughan Williams
Journal:  Eur Heart J       Date:  1984-02       Impact factor: 29.983

2.  Inhibition of Vmax of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium.

Authors:  M Kohlhardt; C Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

Review 3.  Propafenone--a new antiarrhythmic drug.

Authors:  L Seipel; G Breithardt
Journal:  Eur Heart J       Date:  1980-08       Impact factor: 29.983

4.  Some statistical methods useful in circulation research.

Authors:  S Wallenstein; C L Zucker; J L Fleiss
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

5.  The metabolic fate of 2H-labelled propafenone in man.

Authors:  H G Hege; M Hollmann; S Kaumeier; H Lietz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

6.  Electrophysiological effects of propafenone on isolated guinea-pig ventricular muscle and sheep Purkinje fibres.

Authors:  J Tamargo; C Delgado
Journal:  Eur J Pharmacol       Date:  1985-12-03       Impact factor: 4.432

7.  Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations.

Authors:  F Ledda; L Mantelli; S Manzini; S Amerini; A Mugelli
Journal:  J Cardiovasc Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.105

8.  Electrophysiological effects of bunaphtine in guinea-pig ventricular fibers.

Authors:  J Tamargo
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-08

9.  Electrophysiological effects of imipramine on bovine ventricular muscle and Purkinje fibres.

Authors:  S Rodriguez; J Tamargo
Journal:  Br J Pharmacol       Date:  1980-09       Impact factor: 8.739

10.  Clinical pharmacology of propafenone: pharmacokinetics, metabolism and concentration-response relations.

Authors:  L A Siddoway; D M Roden; R L Woosley
Journal:  Am J Cardiol       Date:  1984-11-14       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.